Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome.

Agu PC, Yudas AF, Lu J

Open source

DOI
10.3390/antiox14111364
Published
2025 Nov 17
Container
Antioxidants (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antiox14111364,
  title = {Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome.},
  author = {Agu PC and Yudas AF and Lu J},
  year = {2025},
  journal = {Antioxidants (Basel, Switzerland)},
  doi = {10.3390/antiox14111364},
  url = {https://doi.org/10.3390/antiox14111364}
}

RIS

TY  - JOUR
TI  - Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome.
AU  - Agu PC
AU  - Yudas AF
AU  - Lu J
PY  - 2025
JO  - Antioxidants (Basel, Switzerland)
DO  - 10.3390/antiox14111364
UR  - https://doi.org/10.3390/antiox14111364
ER  - 

APA

PC, A., AF, Y., & J, L. (2025). Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome.. Antioxidants (Basel, Switzerland). https://doi.org/10.3390/antiox14111364

Source records